These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31954540)

  • 1. Survival disparities in vulvar cancer patients in Commission on Cancer®-accredited facilities.
    Gaulin NB; Lesnock JL; Tian C; Osei-Bonsu K; Jacobs A; Richard SD; Krivak TC; Miller EM; Shriver CD; Casablanca Y; Maxwell GL; Darcy KM
    Gynecol Oncol; 2020 Apr; 157(1):136-145. PubMed ID: 31954540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis.
    Gill BS; Bernard ME; Lin JF; Balasubramani GK; Rajagopalan MS; Sukumvanich P; Krivak TC; Olawaiye AB; Kelley JL; Beriwal S
    Gynecol Oncol; 2015 Jun; 137(3):365-72. PubMed ID: 25868965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of treatment and prognosis of 59 cases of vulvar melanoma].
    Yuan GW; Li XG; Li N; Yao HW; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):395-401. PubMed ID: 32842246
    [No Abstract]   [Full Text] [Related]  

  • 4. Midline involvement as a risk factor for vulvar cancer recurrence.
    Stankevica J; Macuks R; Baidekalna I; Donina S
    Asian Pac J Cancer Prev; 2012; 13(10):5237-40. PubMed ID: 23244142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in care for elderly women with endometrial cancer adversely effects survival.
    Torgeson A; Boothe D; Poppe MM; Suneja G; Gaffney DK
    Gynecol Oncol; 2017 Nov; 147(2):320-328. PubMed ID: 28802765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and outcomes for elderly women with vulvar cancer over time.
    Rauh-Hain JA; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Dizon DS; Schorge JO; del Carmen MG
    BJOG; 2014 May; 121(6):719-27; discussion 727. PubMed ID: 24621118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival Benefit of Adjuvant Radiation Therapy in Node-positive Vulvar Cancer.
    Xanthopoulos EP; Grover S; Puri PM; Corradetti MN; Heilbroner SP; Mitra N; Simone CB; Lin LL
    Am J Clin Oncol; 2018 Sep; 41(9):845-850. PubMed ID: 30134287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma: A population-based SweGCG study.
    Hellman K; Holmberg E; Bjurberg M; Borgfeldt C; Dahm-Kähler P; Flöter Rådestad A; Hjerpe E; Högberg T; Marcickiewicz J; Rosenberg P; Stålberg K; Tholander B; Kjølhede P; Åvall-Lundqvist E
    Gynecol Oncol; 2020 Dec; 159(3):663-671. PubMed ID: 32988623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of adjuvant radiation therapy in older patients with node-positive vulvar cancer: A national cancer database analysis.
    Ni L; Sinha S; Rara M; Phuong C; Chen LM; Hsu IJ; Yoshida EJ
    Gynecol Oncol; 2022 Nov; 167(2):189-195. PubMed ID: 36150913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer®-accredited facilities.
    Vaz J; Tian C; Richardson MT; Chan JK; Mysona D; Rao UN; Powell MA; Shriver CD; Hamilton CA; Casablanca Y; Maxwell GL; Darcy KM
    Gynecol Oncol; 2020 Apr; 157(1):121-130. PubMed ID: 31954536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States.
    Stroup AM; Harlan LC; Trimble EL
    Gynecol Oncol; 2008 Mar; 108(3):577-83. PubMed ID: 18155274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of an individualized surgical therapy of vulvar carcinoma from 1973-1993].
    Köhler U; Schöne M; Pawlowitsch T
    Zentralbl Gynakol; 1997; 119 Suppl 1():8-16. PubMed ID: 9245126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database.
    Rao YJ; Chin RI; Hui C; Mutch DG; Powell MA; Schwarz JK; Grigsby PW; Markovina S
    Gynecol Oncol; 2017 Sep; 146(3):572-579. PubMed ID: 28662775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance and prognostic value of femoral lymph node metastasis in FIGO stage III vulvar carcinoma.
    Tu H; Sun P; Gu HF; Zhang XK; Huang H; Wan T; Liu JH
    Eur J Surg Oncol; 2017 Sep; 43(9):1768-1775. PubMed ID: 28602173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study.
    Mahner S; Jueckstock J; Hilpert F; Neuser P; Harter P; de Gregorio N; Hasenburg A; Sehouli J; Habermann A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Thiel F; Mustea A; Meier W; du Bois A; Griebel LF; Woelber L;
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25618900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Versus Preoperative Radiation for Locally Advanced Vulvar Cancer.
    Natesan D; Hong JC; Foote J; Sosa JA; Havrilesky L; Chino J
    Int J Gynecol Cancer; 2017 May; 27(4):794-804. PubMed ID: 28333840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal overall treatment time for adjuvant therapy for women with completely resected, node-positive vulvar cancer.
    Ashmore S; Crafton SM; Miller EM; Krivak TC; Glaser SM; Teterichko SR; Sukumvanich P; Viswanathan AN; Beriwal S; Horne ZD
    Gynecol Oncol; 2021 Apr; 161(1):63-69. PubMed ID: 33500149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
    Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
    Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? A population based study.
    Mahmoud O; Hathout L; Shaaban SG; Elshaikh MA; Beriwal S; Small W
    Gynecol Oncol; 2016 Dec; 143(3):539-544. PubMed ID: 27769525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in Vulvar Cancer Reported by the National Cancer Database: Influence of Sociodemographic Factors.
    Chase DM; Lin CC; Craig CD; Fedewa SA; Virgo KS; Farley JH; Halpern M; Monk BJ
    Obstet Gynecol; 2015 Oct; 126(4):792-802. PubMed ID: 26348176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.